Cargando…

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs

Despite the ability to induce a broad range of cross protection, M2e5x virus-like particles (VLPs) alone provide limited vaccine efficacy and confer low efficacy of protection against highly pathogenic avian influenza virus (HPAIV) infection in chickens. Avian influenza hemagglutinin (HA) has been a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hae-Ji, Chu, Ki-Back, Lee, Dong-Hun, Lee, Su-Hwa, Park, Bo Ryoung, Kim, Min-Chul, Kang, Sang-Moo, Quan, Fu-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597044/ https://www.ncbi.nlm.nih.gov/pubmed/31246961 http://dx.doi.org/10.1371/journal.pone.0216871

Ejemplares similares

Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Neuraminidase in Virus-like Particles Contributes to the Protection against High Dose of Avian Influenza Virus Challenge Infection
por: Kang, Hae-Ji, et al.
Publicado: (2021)

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
por: Wang, Bao-Zhong, et al.
Publicado: (2010)

Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Cross-Protection Induced by Virus-like Particles Derived from the Influenza B Virus
por: Kang, Hae-Ji, et al.
Publicado: (2022)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution
por: Correia, Ricardo, et al.
Publicado: (2020)

Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Influenza virus-like particle vaccine containing both apical membrane antigen 1 and microneme-associated antigen proteins of Plasmodium berghei confers protection in mice
por: Kim, Min-Ju, et al.
Publicado: (2022)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection
por: Kang, Hae-Ji, et al.
Publicado: (2018)

Influenza vaccine efficacy induced by orally administered recombinant baculoviruses
por: Basak, Swarnendu, et al.
Publicado: (2020)

Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses
por: Lee, Su-Hwa, et al.
Publicado: (2019)

Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1
por: Lee, Su-Hwa, et al.
Publicado: (2022)

Protective Immunity Induced by Virus-Like Particle Containing Merozoite Surface Protein 9 of Plasmodium berghei
por: Lee, Su-Hwa, et al.
Publicado: (2020)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin
por: Basak, Swarnendu, et al.
Publicado: (2021)

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice
por: Quan, Fu-Shi, et al.
Publicado: (2010)

Influenza M1 Virus-Like Particles Consisting of Toxoplasma gondii Rhoptry Protein 4
por: Lee, Su-Hwa, et al.
Publicado: (2017)

Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei
por: Kim, Min-Ju, et al.
Publicado: (2022)

Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
por: Song, Jae-Min, et al.
Publicado: (2011)

Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei
por: Lee, Dong-Hun, et al.
Publicado: (2019)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Chimeric influenza-virus-like particles containing the porcine reproductive and respiratory syndrome virus GP5 protein and the influenza virus HA and M1 proteins
por: Xue, Chunyi, et al.
Publicado: (2014)

Experimental infection of chickens, ducks and quails with the highly pathogenic H5N1 avian influenza virus
por: Jeong, Ok-Mi, et al.
Publicado: (2009)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
por: Kim, Ki-Hye, et al.
Publicado: (2018)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
por: Kim, Yu-Jin, et al.
Publicado: (2017)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice
por: Shi, Lili, et al.
Publicado: (2023)

Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection
por: Kim, Min-Chul, et al.
Publicado: (2019)

Genetic and Antigenic Evolution of European Swine Influenza A Viruses of HA-1C (Avian-Like) and HA-1B (Human-Like) Lineages in France from 2000 to 2018
por: Chastagner, Amélie, et al.
Publicado: (2020)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments
por: Bogani, Giorgio, et al.
Publicado: (2020)

Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
por: Bright, Rick A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jcuksfp8rspjkvc50955p89fml